Evidence map›Paper›PMID 28463988›Full record

ArticlePLoS pathogens2017

Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.

Christine M Calton, Matthew P Bronnimann, Ariana R Manson, Shuaizhi Li, Janice A Chapman, Marcela Suarez-Berumen, Tatum R Williamson, Sudheer K Molugu, Ricardo A Bernal, Samuel K Campos

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Christine M CaltonBIO5 Institute, University of Arizona, Tucson, Arizona, United States of America.
Matthew P BronnimannDepartment of Immunobiology, University of Arizona, Tucson, Arizona, United States of America.
Ariana R MansonDepartment of Molecular & Cellular Biology, University of Arizona, Tucson, Arizona, United States of America.ORCID http://orcid.org/0000-0002-7902-6777
Shuaizhi LiDepartment of Cellular & Molecular Medicine, University of Arizona, Tucson, Arizona, United States of America.
Janice A ChapmanBIO5 Institute, University of Arizona, Tucson, Arizona, United States of America.
Marcela Suarez-BerumenDepartment of Molecular & Cellular Biology, University of Arizona, Tucson, Arizona, United States of America.
Tatum R WilliamsonDepartment of Molecular & Cellular Biology, University of Arizona, Tucson, Arizona, United States of America.ORCID http://orcid.org/0000-0002-0659-6250
Sudheer K MoluguDepartment of Chemistry, University of Texas at El Paso, El Paso, Texas, United States of America.ORCID http://orcid.org/0000-0001-9939-1950
Ricardo A BernalDepartment of Chemistry, University of Texas at El Paso, El Paso, Texas, United States of America.ORCID http://orcid.org/0000-0001-5849-8647
Samuel K CamposBIO5 Institute, University of Arizona, Tucson, Arizona, United States of America.ORCID http://orcid.org/0000-0003-1540-9821
University of Arizona · USThe University of Texas at El Paso · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Mechanisms of L2-Mediated Membrane Translocation of the Papillomaviral GenomeR01AI108751 · NIAID · UNIVERSITY OF ARIZONA · PI CAMPOS, SAMUEL K · 2014 to 2018
$1.8M
Structural Significance of Point Mutations within the Human hsp60 ChaperoninSC3GM113805 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI BERNAL, RICARDO A · 2015 to 2018
$453k
NCI NIH HHS P30 CA023074NIAID NIH HHS R01 AI108751NIGMS NIH HHS SC3 GM113805
6 · The paper itself

Abstract

The human papillomavirus type 16 (HPV16) L2 protein acts as a chaperone to ensure that the viral genome (vDNA) traffics from endosomes to the trans-Golgi network (TGN) and eventually the nucleus, where HPV replication occurs. En route to the nucleus, the L2/vDNA complex must translocate across limiting intracellular membranes. The details of this critical process remain poorly characterized. We have developed a system based on subcellular compartmentalization of the enzyme BirA and its cognate substrate to detect membrane translocation of L2-BirA from incoming virions. We find that L2 translocation requires transport to the TGN and is strictly dependent on entry into mitosis, coinciding with mitotic entry in synchronized cells. Cell cycle arrest causes retention of L2/vDNA at the TGN; only release and progression past G2/M enables translocation across the limiting membrane and subsequent infection. Microscopy of EdU-labeled vDNA reveals a rapid and dramatic shift in vDNA localization during early mitosis. At late G2/early prophase vDNA egresses from the TGN to a pericentriolar location, accumulating there through prometaphase where it begins to associate with condensed chromosomes. By metaphase and throughout anaphase the vDNA is seen bound to the mitotic chromosomes, ensuring distribution into both daughter nuclei. Mutations in a newly defined chromatin binding region of L2 potently blocked translocation, suggesting that translocation is dependent on chromatin binding during prometaphase. This represents the first time a virus has been shown to functionally couple the penetration of limiting membranes to cellular mitosis, explaining in part the tropism of HPV for mitotic basal keratinocytes.

Indexed as

MitosisBiological TransportCapsid ProteinsCell Cycle CheckpointsCell LineCell NucleusDNA, ViralEndosomesGenome, ViralHuman papillomavirus 16HumansKeratinocytesMutationOncogene Proteins, ViralPapillomavirus Infectionstrans-Golgi NetworkCapsid ProteinsDNA, ViralL2 protein, Human papillomavirus type 16Oncogene Proteins, Viral

Identifiers

PMID28463988
PMCPMC5412990
OpenAlexW2611626290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.